Skip to main content

Advertisement

Table 3 Neurocognitive and quality of life assessment compliance

From: The efficacy and roles of combining temozolomide with whole brain radiotherapy in protection neurocognitive function and improvement quality of life of non-small-cell lung cancer patients with brain metastases

Evaluation Status RCT arm RT arm P
Not evaluated Received Not evaluated Received  
Hopkins Verbal Learning Test (HVLT-R)
 Baseline 5 124 4 105 0.93
 At 3 Months 24 105 32 87 0.12
 At 5 Months 57 72 55 64 0.75
 At 7 Months 87 42 83 36 0.70
Trail-making Test (TMT)
 Baseline 6 123 4 105 0.71
 At 3 Months 26 103 31 88 0.27
 At 5 Months 59 70 57 62 0.73
 At 7 Months 85 44 83 36 0.52
Controlled Oral Word Association (COWA) test
 Baseline 5 124 6 103 0.55
 At 3 Months 24 105 30 89 0.21
 At 5 Months 57 72 58 61 0.47
 At 7 Months 85 44 85 34 0.35
Functional Assessment of Cancer Treatment-Lung (FACT-L)
 Baseline 7 122 9 100 0.48
 At 3 Months 27 102 34 85 0.16
 At 5 Months 56 73 54 65 0.76
 At 7 Months 88 41 86 33 0.49
  1. Abbreviations: Hopkins Verbal Learning Test HVLT-R, Trail-making Test TMT, Controlled Oral Word Association test COWA, Functional Assessment of Cancer Treatment-Lung FACT-L